Pages that link to "Q44464485"

The following pages link to Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis (Q44464485):

Displaying 14 items.

• What is new in the management of rapidly progressive glomerulonephritis? (Q28259540) (← links)
• Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond (Q33620537) (← links)
• Effect of Shenkang granules on the progression of chronic renal failure in 5/6 nephrectomized rats (Q35758051) (← links)
• The emergence of the glomerular parietal epithelial cell. (Q38182323) (← links)
• PDGF and the progression of renal disease. (Q38185014) (← links)
• Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. (Q38259755) (← links)
• Renal effects of targeted anticancer therapies (Q38367168) (← links)
• Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review (Q49188770) (← links)
• Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime. (Q54977339) (← links)
• B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis (Q85282997) (← links)
• Arg mediates LPS-induced disruption of the pulmonary endothelial barrier (Q91512516) (← links)
• The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-β in the mesangial proliferative glomerulonephritis therapy (Q91555360) (← links)
• The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression (Q92153518) (← links)
• Podocyte Injury in Lupus Nephritis (Q93016595) (← links)